about
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.Prolonged treatment time deteriorates positioning accuracy for stereotactic radiosurgery.Clinicopathologic features and responses to radiotherapy of myeloid sarcoma.Mechanisms of trastuzumab resistance and their clinical implications.14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival.Good tolerance and long-term complete remission after definitive intensity-modulated radiotherapy for locally advanced head and neck cancer in a patient with human immunodeficiency virus infection: A case report and literature review.Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis.Preoperative prognostic neurologic index for glioblastoma patients receiving tumor resection.Medulloblastoma in adults. Treatment outcome, relapse patterns, and prognostic factors.
P50
Q27824819-91C8A81B-11A2-40C0-AD0A-FF91FAFD57C3Q30412841-A058BCE0-30BC-4CFE-B0D7-90C3CB30A08BQ33592357-6491FFA7-CFEA-4D0F-BE23-81758A7FDF2FQ36355193-0B4F876E-D647-4740-AC34-12A931069171Q37165239-F5B3DC30-838E-47FD-9A26-2831A6435D1FQ38395418-F12BF1FE-608B-472B-B3A3-2E05B5C7CD5FQ40073729-A8F4EF04-06E7-4184-AAE3-53C87EA5F220Q44017734-79196AB9-4061-46C1-8BC5-5078EF55C212Q44605769-2EEA9F5E-7883-4308-AADD-E8B0E801729FQ48402793-784A1C25-C5D1-42D9-AB11-22C058E84272
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1575-5620
@en
name
Keng-Hsueh Lan
@ast
Keng-Hsueh Lan
@en
Keng-Hsueh Lan
@es
Keng-Hsueh Lan
@nl
type
label
Keng-Hsueh Lan
@ast
Keng-Hsueh Lan
@en
Keng-Hsueh Lan
@es
Keng-Hsueh Lan
@nl
prefLabel
Keng-Hsueh Lan
@ast
Keng-Hsueh Lan
@en
Keng-Hsueh Lan
@es
Keng-Hsueh Lan
@nl
P106
P31
P496
0000-0002-1575-5620